All details about Gujarat Kidney and Super Speciality IPO
The healthcare provider accounts for more than a third of the total capital that will be raised next week and will open for subscription on December 22. Ahead of the issue opening, the GMP is around 7% over the issue price of Rs 114 at the upper end.
Gujarat Kidney operates a network of multispeciality hospitals across Gujarat with a focus on renal sciences and secondary and tertiary care.
The company plans to use the IPO proceeds largely for inorganic expansion, including the acquisition of Parekhs Hospital in Ahmedabad, funding a new hospital in Vadodara, and buying advanced medical equipment such as robotics systems.
It will also deploy part of the funds to reduce debt and strengthen its balance sheet. The IPO is entirely a fresh issue, valuing the company at a pre-issue market capitalisation of nearly Rs 900 crore.
SME segment to dominate IPOs next week
Other than Gujarat Kidney, the pipeline is dominated by the SME segment. Around 10 small and medium enterprises are together aiming to raise around Rs 420 crore through listings on the BSE SME and NSE SME platforms.These include Apollo Techno Industries, Bai Kakaji Polymers, Admach Systems, Nanta Tech, Dhara Rail Projects, Sundrex Oil, Shyam Dhani Industries, Dachepalli Publishers and EPW India. Issue sizes in the SME basket range from about Rs 31 crore to just over Rs 105 crore.
The biggest of the lot is from Bai Kakaji Polymers, which is looking to raise around Rs 105 crore. The company, which makes plastic and polymer-based products, fixed a price band of Rs 186 apiece.
5 listings scheduled next week
While fundraising activity remains steady, the listing calendar next week is equally busy with about 5 IPOs listing next week. KSH International will be the only mainboard listing among them.
KSH International’s IPO had initially struggled to attract demand and was undersubscribed at about 83%, but eventually sailed through after the company reduced the size of the offer. The stock currently carries a grey market premium of zero, indicating muted expectations ahead of listing.
Also read: Stock market meets physics: 5 laws that explain why prices move the way they do
The GMPs for other SME listings slated next week are also negligible, suggesting that investors are tempering expectations after a volatile year for IPO returns, particularly in the SME space.
(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of Economic Times)